Profile data is unavailable for this security.
About the company
Sinotherapeutics Inc is China-based company mainly engaged in the research and development, commercial production and sales of pharmaceutical preparations. The Company's main businesses include research and development, production and sales of generic drugs, as well as contract research and development organization (CRO) services. The Company mainly operates in the domestic market and overseas markets.
- Revenue in CNY (TTM)368.86m
- Net income in CNY76.25m
- Incorporated2012
- Employees260.00
- LocationSinotherapeutics IncSHANGHAI 201203ChinaCHN
- Phone+86 2 168819009
- Fax+86 2 168819009
- Websitehttps://www.sinotherapeutics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai New World Co Ltd | 1.15bn | 33.59m | 3.63bn | 1.20k | 108.05 | 0.8633 | -- | 3.17 | 0.0519 | 0.0519 | 1.77 | 6.50 | 0.2026 | 4.62 | 7.42 | 951,798.10 | 0.5858 | 0.5242 | 0.78 | 0.7249 | 38.56 | 33.70 | 2.89 | 2.71 | 1.52 | -- | 0.1222 | 82.75 | 33.39 | -16.40 | 160.85 | -35.00 | 53.61 | -25.42 |
| Chengdu Olymvax Biopharmaceuticals Inc | 500.05m | -12.30m | 3.71bn | 471.00 | -- | 4.14 | -- | 7.41 | -0.0303 | -0.0303 | 1.23 | 2.21 | 0.3338 | 0.4197 | 1.08 | 1,061,669.00 | -1.22 | 3.17 | -1.70 | 4.68 | 93.29 | 93.00 | -3.64 | 7.44 | 1.92 | -3.90 | 0.2505 | 9.82 | -9.38 | 45.40 | -33.94 | -- | 56.47 | -- |
| Beijing Konruns Pharmaceutical Co Ltd | 954.14m | 166.44m | 3.73bn | 447.00 | 22.02 | 1.18 | -- | 3.91 | 1.06 | 1.06 | 6.05 | 19.78 | 0.2548 | 2.50 | 3.73 | 2,134,547.00 | 5.46 | 5.43 | 6.39 | 6.24 | 88.29 | 89.93 | 21.44 | 20.76 | 3.08 | -- | 0.0486 | 21.53 | 6.15 | -2.08 | 48.24 | -10.63 | 43.05 | -9.71 |
| Hunan Warrant Pharmaceutical Co Ltd | 1.45bn | 222.11m | 3.74bn | 1.16k | 16.86 | 2.10 | -- | 2.59 | 2.37 | 2.37 | 15.44 | 19.01 | 0.6713 | 1.50 | 8.93 | 1,246,491.00 | 9.31 | 11.21 | 11.21 | 14.05 | 64.09 | 69.00 | 13.88 | 13.96 | 3.02 | -- | 0.0252 | 8.05 | 10.84 | 18.50 | 15.60 | 19.02 | 24.49 | -- |
| Hainan Huluwa Pharmaceutical Grop Co Ltd | 1.81bn | 94.97m | 3.79bn | 2.47k | 39.86 | 3.29 | -- | 2.09 | 0.2374 | 0.2374 | 4.52 | 2.87 | 0.6721 | 2.88 | 3.81 | 732,708.90 | 3.80 | 5.81 | 6.29 | 9.78 | 50.33 | 58.01 | 5.66 | 7.03 | 0.8245 | 7.04 | 0.5246 | 21.74 | 25.75 | 14.13 | 24.29 | 1.16 | 46.37 | -- |
| Sinotherapeutics Inc | 368.86m | 76.25m | 3.79bn | 260.00 | 49.71 | 3.16 | -- | 10.27 | 0.1682 | 0.1682 | 0.8137 | 2.65 | 0.275 | 3.08 | 5.83 | 1,418,710.00 | 5.69 | -- | 6.09 | -- | 51.77 | -- | 20.67 | -- | 9.09 | -- | 0.00006 | -- | 21.13 | -- | -34.29 | -- | -- | -- |
| Jinyao Pharmaceutical Co Ltd | 3.66bn | 107.59m | 3.81bn | 2.68k | 35.36 | 1.26 | -- | 1.04 | 0.0984 | 0.0984 | 3.35 | 2.76 | 0.5738 | 2.28 | 9.37 | 1,365,219.00 | 2.33 | 1.91 | 4.17 | 3.40 | 42.61 | 46.33 | 4.06 | 3.31 | 0.7584 | 27.18 | 0.2064 | 44.40 | 2.55 | 9.28 | 230.60 | -4.22 | -9.58 | 9.21 |
Data as of Jul 24 2024. Currency figures normalised to Sinotherapeutics Inc's reporting currency: Chinese Yuan Renminbi CNY
8.55%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 1.73m | 4.02% |
| Gfund Management Co., Ltd.as of 31 Dec 2023 | 861.10k | 2.00% |
| Golden Trust Sinopac Fund Management Co., Ltd.as of 31 Dec 2023 | 377.00k | 0.88% |
| Shanghai Guotai Junan Securities Assets Management Co., Ltd.as of 31 Dec 2023 | 232.38k | 0.54% |
| Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 164.10k | 0.38% |
| Truvalue Asset Management Co. Ltd.as of 31 Dec 2023 | 144.06k | 0.33% |
| Guotai Asset Management Co., Ltd.as of 31 Dec 2023 | 132.31k | 0.31% |
| Da Cheng Fund Management Co., Ltd.as of 31 Dec 2023 | 14.31k | 0.03% |
| Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 14.28k | 0.03% |
| China Merchants Fund Management Co., Ltd.as of 31 Dec 2023 | 12.04k | 0.03% |
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
